Over the past year, the Karen Toffler Charitable Trust has returned to a simple but important observation in science: progress is not only shaped by discovery but also sustained by continuity.
Recent analyses published in the Proceedings of the National Academy of Sciences in 2025 underscore how fragile that continuity can be. In early 2025, funding agencies unexpectedly terminated more than 2,000 active research grants, disrupting billions of dollars in ongoing work and altering the trajectories of thousands of research programs.
These numbers tell only part of the story. Research does not pause neatly. It advances through people and teams working across years to pursue questions that rarely align with funding cycles. When funding agencies withdraw support, projects do not simply stop. Researchers lose momentum, confidence erodes, and in some cases, careers are derailed.
The Fragility of Research Continuity
For the past five years, KTCT has focused on sustaining that continuity. We have consistently deployed approximately $600,000 to $700,000 annually, supporting 12 to 16 early-career researchers. While modest relative to large institutional funders, this level of targeted investment reaches researchers at critical inflection points where timely funding can determine whether work advances or stalls.
This vulnerability is most acute among early-career researchers, specifically PhD candidates, postdoctoral fellows, and assistant professors. At this stage, funding continuity often determines not only the trajectory of a project but also whether a researcher remains in the field.
We see this directly through our Scholars. For some, KTCT funding arrives just as other sources become uncertain. For others, it creates space to pursue ideas that fall outside traditional funding frameworks. These moments are rarely visible externally, but they are decisive.
Investing at the Point of Uncertainty
KTCT does not operate as a substitute for existing systems. We work within a broader research ecosystem that depends on different forms of support at different stages. Our focus is where uncertainty is highest, and potential is still forming, particularly at the earliest stages of independence.
We support early-stage, high-risk ideas not because they are easy to evaluate, but because they are least likely to receive funding through conventional channels. These ideas require belief before they are fully proven. By supporting them, we preserve intellectual diversity and enable exploration that may not yet fit established frameworks.
Research continues to highlight the structural nature of these challenges. Analyses published by the National Institutes of Health in 2023 show that early-career investigators face lower funding success rates and longer timelines to secure independent grants. A 2022 study in Nature Human Behaviour demonstrates that these delays influence long-term career persistence.
Gender disparities further compound the issue. A 2024 study in Nature found that women principal investigators receive smaller grants on average and face lower funding success rates in competitive programs. Findings from the National Science Foundation in 2023 show how early funding gaps can cascade over time, shaping publication output, visibility, and future opportunity.
These patterns reinforce a broader reality: the research ecosystem is not continuous. It is uneven and often fragile at the earliest stages.
It is where targeted, flexible funding matters most.
Over the history of KTCT, we have seen how relatively modest support, delivered at the right moment, can sustain both the work and the people behind it. It allows researchers to continue asking questions, testing ideas, and building the foundation for future breakthroughs.
It also highlights the importance of partnership. Institutions, mentors, and collaborators strengthen the work we support by recognizing the value of early investment. No single organization can address these challenges alone, but aligned efforts can stabilize the system where it is most vulnerable.
This approach reflects a broader shift in research philanthropy. Studies from the Wellcome Trust in 2021 and the Howard Hughes Medical Institute in 2020 show that flexible, investigator-led funding increases creativity, supports breakthrough discoveries, and improves retention of talented researchers.
We remain committed to supporting work that requires patience, curiosity, and resilience. Because today’s research environment does not guarantee continuity. It must be intentionally supported.
We invite partners, institutions, and individuals to join us in this effort. With expanded support, we can fund more early-career researchers, extend the reach of high-potential ideas, and accelerate progress in brain health and neurodegenerative disease research.
Together, we can ensure that promising science continues and that the people driving it forward have the support they need to succeed.